RLAY
Relay Therapeutics, Inc. · Healthcare · Biotechnology
动量输入(同类管理人):
持有人广度 -6.7% ·
股份流向 -3.9% ·
净新建仓位 -14.3%
· 公式
广泛减持:持股数量下降,持有人数量减少
所有持股数据:仅限已追踪的 13F 管理人,普通股持仓,报告期 Q3 2025
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 53.97K | $939,635 | n/a | n/a |
| Q2 2026 | 93 | +6 | 111.07M | $2.04B | +13 | −9 |
| Q1 2026 | 92 | +9 | 68.30M | $679.13M | +15 | −7 |
| Q4 2025 | 84 | +2 | 73.82M | $624.52M | +3 | n/a |
| Q3 2025 | 14 | -1 | 56.07M | $292.70M | n/a | −2 |
| Q2 2025 | 13 | 0 | 54.62M | $188.99M | +1 | −1 |
| Q1 2025 | 10 | -2 | 33.93M | $88.91M | n/a | −2 |
| Q4 2024 | 12 | 0 | 26.38M | $108.69M | n/a | n/a |
| Q3 2024 | 11 | 0 | 24.01M | $170.03M | +2 | −2 |
| Q2 2024 | 11 | n/a | 15.37M | $100.25M | n/a | n/a |
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management ✦ | 14.77M | +9.9% | $77.12M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 2 | BlackRock ✦ (被动) | 13.76M | -1.4% | $71.82M | 0.0% | ▼ Trim | 2 | SEC ↗ ×12 |
| 3 | The Vanguard Group ✦ (被动) | 9.40M | +0.2% | $49.05M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 4 | State Street Global Advisors ✦ (被动) | 5.07M | -2.6% | $26.44M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 3.05M | -5.4% | $15.95M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 6 | Goldman Sachs Group ✦ | 1.87M | n/a | $9.76M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 7 | Morgan Stanley ✦ | 1.76M | n/a | $9.21M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 8 | AQR Capital Management ✦ | 1.30M | +20.1% | $6.79M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 9 | T. Rowe Price ✦ | 1.14M | -60.4% | $5.94M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 10 | Two Sigma Investments ✦ | 1.10M | +7.1% | $5.72M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 1.02M | -32.2% | $5.34M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 12 | JPMorgan Chase ✦ | 924.76K | n/a | $4.83M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 13 | Millennium Management ✦ | 744.04K | -60.2% | $3.88M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 14 | Fidelity (FMR) ✦ | 162.74K | +2.9% | $849,511 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例,即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Norges Bank | $2.89M | 曾为 0.0% |
| Marshall Wace | $178,874 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构(SEC结构化数据, Q1 2026): 240 持有人, 183.00M 股份, $1.79B 已申报. 这是与上方被追踪全域数据不同的较早期间,两者从不混用。
持有该证券的受追踪机构最常同时持有的其他证券:基于共同持有计数,而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Officer, Director · 48.20K 股 · $872,402
Officer · 17.51K 股 · $325,354
Officer · 206 股 · $3,968
Officer · 17.72K 股 · $335,560
Officer · 8.53K 股 · $161,814
Officer, Director · 48.20K 股 · $912,889
Officer · 4.51K 股 · $90,295
10% owner · 6.00M 股 · $116.40M
Officer · 17.72K 股 · $349,734
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论